LXRXLexicon Pharmaceuticals, Inc.
$1.41-4.1% 1Y
$1.41
$1.1452 weeks$2.63
Is the price fair?
What LXRX's price assumes
Lexicon Pharmaceuticals, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 15.1× revenue.
15.1
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 3.59
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 11.8
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 3.59
- EV / EBIToperating margin −131%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 11.8
- Market capitalisation445.0 million shares, counted Aug 3, 2026
- $627M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.